MR‐guided simulation is superior than FDG/PET‐guided simulation for local control in nasopharyngeal cancer patients treated with intensity‐modulated radiotherapy
Authors:
- 10 August 2020
- journal article
- research article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 17 (1) , 43-51
Abstract
Background: MRI and PET/CT scans are the main supportive methods for nasopharyngeal cancer (NPC) for staging and planning. The aim of this study is to compare MRI and PET/CT scanning in terms of survival in patients with NPC who had MRI or PET/CT‐simulated radiotherapy planning.Methods: Pathological diagnosed nonkeratinized undifferentiated type and stage II‐IVA 91 NPC patients with treated intensity‐modulated radiotherapy plus chemotherapy were scanned. The patients were immobilized by a customized thermoplastic mask for fusion images both MRI scans and PET/CT scans. CTVs were created via MR‐guided simulation and PET/CT‐guided simulation.Results: PET/CT‐guided simulation was performed with 44 patients (56.4%) and MR‐guided simulation was performed with 34 patients (43.6%). Local recurrence‐free survival (LRFS) of patients was 68.1 months. LRFS of patients with PET/CT‐guided simulation was 59.9, while LRFS of patients with MR‐guided was 66.9 months. There was a statistically significant difference between groups (P = .03). In the subgroup analyses, the patients were assessed by dividing into the three groups for the T1‐T2 stage, T‐3 stage, and T‐4 stage. In the patients with T1‐T2 stage, 5‐year LRFS rates were found %74.4 for PET/CT‐guided simulation and %83.3 for MR‐guided simulation. There was no statistically significant difference between groups (P = .33). In the patients with T‐3 stage, 5‐year LRFS rates were found %55.6 for PET/CT‐guided simulation and %83.3 for MR‐guided simulation. There was not a statistically significant difference between groups (P = .59). In the patients with T‐4 stage, 5‐year LRFS rates were found %42.2 for PET/CT‐guided simulation and %85.1 for MR‐guided simulation. The difference between groups was found to be statistically significant (P = .04).Conclusion: In this study, we founded that MR‐guided simulation has better than PET/CT‐guided simulation for LRFS.Keywords
This publication has 23 references indexed in Scilit:
- Accuracy of 18 F-flurodeoxyglucosepositron emission tomography/computed tomography in the staging of newly diagnosed nasopharyngeal carcinoma: a systematic review and meta-analysisRadiology and Oncology, 2014
- Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: A systematic review and meta-analysisEuropean Journal of Radiology, 2013
- Heterogeneity in head and neck IMRT target design and clinical practiceRadiotherapy and Oncology, 2012
- 18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck Cancer: a correlation study between suitable uptake value threshold and tumor parametersRadiation Oncology, 2010
- Decreased 3D observer variation with matched CT-MRI, for target delineation in Nasopharynx cancerRadiation Oncology, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinomaRadiation Oncology, 2008
- Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-upEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomographyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005